Electrocardiographic markers of subclinical atrial fibrillation detected by implantable loop recorder: insights from the LOOP Study

Abstract Aims Insights into subclinical atrial fibrillation (AF) development are warranted to inform the strategies of screening and subsequent clinical management upon AF detection. Hence, this study sought to characterize the onset and progression of subclinical AF with respect to 12-lead electrocardiogram (ECG) parameters. Methods and results We included AF-naïve individuals aged 70–90 years with additional stroke risk factors who underwent implantable loop recorder (ILR) monitoring in the LOOP Study. Using data from daily ILR recordings and the computerized analysis of baseline ECG, we studied empirically selected ECG parameters for AF detection (≥6 min), cumulative AF burden, long-lasting AF (≥24 h), and AF progression. Of 1370 individuals included, 419 (30.6%) developed AF during follow-up, with a mean cumulative AF burden of 1.5% [95% CI: 1.2–1.8]. Several P-wave-related and ventricular ECG parameters were associated with new-onset AF and with cumulative AF burden in AF patients. P-wave duration (PWD), P-wave terminal force in Lead V1, and interatrial block (IAB) further demonstrated significant associations with long-lasting AF. Among AF patients, we observed an overall reduction in cumulative AF burden over time (IRR 0.70 [95% CI: 0.51–0.96]), whereas IAB was related to an increased risk of progression to AF ≥24 h (HR 1.86 [95% CI: 1.02–3.39]). Further spline analysis also revealed longer PWD to be associated with this progression in AF duration. Conclusion We identified several ECG parameters associated with new-onset subclinical AF detected by ILR. Especially PWD and IAB were robustly related to the onset and the burden of AF as well as progression over time.

[1]  G. Boriani,et al.  Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry , 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  I. V. Van Gelder,et al.  Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper'. , 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  P. Noseworthy,et al.  Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial , 2022, The Lancet.

[4]  R. Providência,et al.  Clinical applications of heart rhythm monitoring tools in symptomatic patients and for screening in high-risk groups. , 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  F. Dahl,et al.  Prediction of occult atrial fibrillation in patients after cryptogenic stroke and transient ischaemic attack: PROACTIA , 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  G. Hindricks,et al.  P-wave duration and atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis , 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  B. Gorenek,et al.  P Wave Parameters and Indices: A Critical Appraisal of Clinical Utility, Challenges, and Future Research—A Consensus Document Endorsed by the International Society of Electrocardiology and the International Society for Holter and Noninvasive Electrocardiology , 2022, Circulation. Arrhythmia and electrophysiology.

[8]  A. Brandes,et al.  Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial , 2021, The Lancet.

[9]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[10]  Mathias Buus Lanng,et al.  Natural History of Subclinical Atrial Fibrillation Detected by Implanted Loop Recorders. , 2019, Journal of the American College of Cardiology.

[11]  L. Chen,et al.  Relationship between QRS duration and incident atrial fibrillation. , 2018, International journal of cardiology.

[12]  T. N. Harrison,et al.  Association of Burden of Atrial Fibrillation With Risk of Ischemic Stroke in Adults With Paroxysmal Atrial Fibrillation: The KP-RHYTHM Study , 2018, JAMA cardiology.

[13]  J. Svendsen,et al.  Risk Prediction of Atrial Fibrillation Based on Electrocardiographic Interatrial Block , 2018, Journal of the American Heart Association.

[14]  Rajiv Mahajan,et al.  Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis , 2018, European heart journal.

[15]  L. Chen,et al.  Refining Prediction of Atrial Fibrillation Risk in the General Population With Analysis of P-Wave Axis (from the Atherosclerosis Risk in Communities Study). , 2017, The American journal of cardiology.

[16]  Giuseppe Boriani,et al.  Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden. , 2017, Heart rhythm.

[17]  A. Brandes,et al.  Atrial fibrillation detected by continuous electrocardiographic monitoring using implantable loop recorder to prevent stroke in individuals at risk (the LOOP study): Rationale and design of a large randomized controlled trial , 2017, American heart journal.

[18]  Wesley T. O’Neal,et al.  Frontal QRS‐T Angle and the Risk of Atrial Fibrillation in the Elderly , 2017, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[19]  J. Uhm,et al.  Low P-wave amplitude (<0.1 mV) in lead I is associated with displaced inter-atrial conduction and clinical recurrence of paroxysmal atrial fibrillation after radiofrequency catheter ablation. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[20]  Børge G Nordestgaard,et al.  P-wave duration and the risk of atrial fibrillation: Results from the Copenhagen ECG Study. , 2015, Heart rhythm.

[21]  H. Huikuri,et al.  Prevalence and Prognostic Significance of Abnormal P Terminal Force in Lead V1 of the ECG in the General Population , 2014, Circulation. Arrhythmia and electrophysiology.

[22]  Helmut Pürerfellner,et al.  Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices. , 2014, Journal of the American College of Cardiology.

[23]  S. Cummings,et al.  The QT interval and risk of incident atrial fibrillation. , 2013, Heart rhythm.

[24]  Jesper Hastrup Svendsen,et al.  Risk of atrial fibrillation as a function of the electrocardiographic PR interval: results from the Copenhagen ECG Study. , 2013, Heart rhythm.

[25]  Jesper Hastrup Svendsen,et al.  J-shaped association between QTc interval duration and the risk of atrial fibrillation: results from the Copenhagen ECG study. , 2013, Journal of the American College of Cardiology.

[26]  A. Capucci,et al.  Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.

[27]  Christian Gieger,et al.  Genome-wide association study of PR interval , 2010, Nature Genetics.

[28]  M. Gold,et al.  Long-term Outcomes in Individuals With Prolonged PR Interval or First-Degree Atrioventricular Block , 2010 .